Artificial intelligence news.
Straight from the original announcements.

Cambridge researcher joins £10m initiative on respiratory infections

November 6, 2026, 08:00Source: Cambridge Computer Science and Technology

Cecilia Mascolo, Professor of Mobile Systems at the University of Cambridge, is joining a £10m national initiative focused on patients with flu, Covid and other serious respiratory illnesses. The Community Respiratory Infection Screening and Prognostics hub, known as CRISP, is government-funded.

Key points
  • Cecilia Mascolo is joining the CRISP initiative.
  • Mascolo is Professor of Mobile Systems at Cambridge.
  • CRISP has £10m in government funding.
  • The Engineering and Physical Sciences Research Council is funding CRISP.
  • The initiative focuses on flu, Covid and other serious respiratory illnesses.

Cambridge researcher joins CRISP

Mascolo is one of the collaborators involved in CRISP, according to the Department of Computer Science and Technology at Cambridge. The initiative is described as a new national programme intended to help patients affected by serious respiratory infections.

The Cambridge researcher develops mobile and wearable health sensing tools. Her involvement links that area of research with CRISP's focus on respiratory infection screening and prognostics.

A £10m government-funded initiative

CRISP has funding of £10m and is government-funded. The Engineering and Physical Sciences Research Council is providing the funding, according to the Cambridge announcement.

The initiative's full name is the Community Respiratory Infection Screening and Prognostics hub. Its scope includes flu, Covid and other serious respiratory illnesses.

Why the collaboration matters

The announcement places mobile and wearable health sensing within a national effort addressing respiratory infections. For Cambridge, the project gives Mascolo a role in a collaboration focused on helping patients with illnesses that include flu and Covid.

The source does not provide further details about CRISP's timetable, participating organisations, specific technologies or expected results. It identifies Mascolo as one of the collaborators and confirms the initiative's funding and respiratory health focus.

Related news

AWS commits $100 million to expand health services worldwide
BusinessNovember 9, 2026, 15:00

AWS commits $100 million to expand health services worldwide

AWS is committing $100 million over five years in AI, agentic services, and cloud infrastructure to organizations working to close health gaps affecting underserved…

PSG’s Anna AI Receives Vizient Innovative Technology Designation
Products and toolsNovember 5, 2026, 16:44

PSG’s Anna AI Receives Vizient Innovative Technology Designation

PSG Global Solutions’ Anna AI has received an Innovative Technology designation from Vizient, recognizing the generative AI solution’s potential to support healthcare…

Business
BusinessNovember 5, 2026, 08:18

Evotec Q3 revenue hits €164.9 m as Horizon savings run ahead of plan

Evotec SE reported Q3 2026 Group revenue of €164.9 m and nine-month revenue of €465.0 m, while reaffirming its full-year guidance. The Hamburg-based drug discovery and…